High concordance between self-reported medication and official prescription database information.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 17712552)

Published in Eur J Clin Pharmacol on August 22, 2007

Authors

Jari Haukka1, Jaana Suvisaari, Annamari Tuulio-Henriksson, Jouko Lönnqvist

Author Affiliations

1: Department for Mental Health and Alcohol Research, Mannerheimintie 166, 00300, Helsinki, Finland. jari.haukka@ktl.fi

Articles citing this

Cemented or uncemented hemiarthroplasty for the treatment of femoral neck fractures? Acta Orthop (2014) 1.45

High validity of mother-reported use of antiasthmatics among children: a comparison with a population-based prescription database. J Clin Epidemiol (2011) 1.27

Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) study. Clin Epidemiol (2013) 1.09

Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study. Int Clin Psychopharmacol (2014) 0.94

Antiepileptic drug use in community-dwelling and institutionalized elderly: a nationwide study of over 1,300,000 older people. Eur J Clin Pharmacol (2011) 0.84

Inverse probability weighting and doubly robust methods in correcting the effects of non-response in the reimbursed medication and self-reported turnout estimates in the ATH survey. BMC Public Health (2014) 0.82

Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons. Clin Epidemiol (2016) 0.82

The association between use of cardiovascular drugs and antidepressants: a nationwide register-based study. Eur J Clin Pharmacol (2008) 0.79

Drug expenditure of high-cost patients and their characteristics in Finland. Eur J Health Econ (2012) 0.79

The relationship between self-reported and registry-based data on use of psychoactive medications in postmenopausal women. BMC Psychiatry (2013) 0.77

Prevalence of and factors related to the use of antidepressants and benzodiazepines: results from the Singapore Mental Health Study. BMC Psychiatry (2013) 0.75

Dopaminergic and serotonergic drug use: a nationwide register-based study of over 1,300,000 older people. PLoS One (2011) 0.75

Concomitant use of two or more antipsychotic drugs is common in Sweden. Ther Adv Psychopharmacol (2015) 0.75

Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease. J Alzheimers Dis (2016) 0.75

Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer's disease. Eur J Clin Pharmacol (2017) 0.75

Articles cited by this

Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull (1998) 4.51

Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry (2001) 4.04

Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry (2006) 2.53

Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ (2006) 2.14

Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study. BMJ (2006) 1.51

Use of health care databases in pharmacoepidemiology. Basic Clin Pharmacol Toxicol (2006) 1.49

Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr Res (2004) 1.44

Linkage disequilibrium in isolated populations: Finland and a young sub-population of Kuusamo. Eur J Hum Genet (2000) 1.27

Schizophrenia in the genetic isolate of Finland. Am J Med Genet (1997) 1.22

The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand (2004) 1.19

Comparison of different methods to estimate prevalence of drug use by using pharmacy records. J Clin Epidemiol (2001) 1.17

Templates for analysis of individual-level prescription data. Basic Clin Pharmacol Toxicol (2006) 0.95

[Anatomic-therapeutic-chemical classification of drugs]. Med Arh (1999) 0.90

Articles by these authors

Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25

Common variants conferring risk of schizophrenia. Nature (2009) 10.37

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet (2009) 7.45

Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44

Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63

Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry (2007) 6.20

Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet (2008) 4.78

Completed suicide after a suicide attempt: a 37-year follow-up study. Am J Psychiatry (2004) 3.92

Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02

Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry (2006) 2.53

Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry (2005) 2.48

Incidence of schizophrenia in a nationwide cohort of patients with type 1 diabetes mellitus. Arch Gen Psychiatry (2007) 2.45

High concordance of bipolar I disorder in a nationwide sample of twins. Am J Psychiatry (2004) 2.24

Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet (2011) 2.21

A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord (2007) 2.16

The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual Life Res (2006) 2.16

Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ (2006) 2.14

Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Br J Psychiatry (2010) 2.09

Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatry (2002) 2.08

Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc Natl Acad Sci U S A (2007) 2.04

Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls. PLoS One (2010) 2.03

Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry (2004) 2.01

A population-specific HTR2B stop codon predisposes to severe impulsivity. Nature (2010) 2.00

Depressive symptoms in adolescence as predictors of early adulthood depressive disorders and maladjustment. Am J Psychiatry (2002) 1.93

Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry (2007) 1.93

Fertility of patients with schizophrenia, their siblings, and the general population: a cohort study from 1950 to 1959 in Finland. Am J Psychiatry (2003) 1.92

Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet (2003) 1.87

Spatial working memory as an endophenotype for schizophrenia. Biol Psychiatry (2003) 1.83

The relationship between job-related burnout and depressive disorders--results from the Finnish Health 2000 Study. J Affect Disord (2005) 1.67

The association between burnout and physical illness in the general population--results from the Finnish Health 2000 Study. J Psychosom Res (2006) 1.61

Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. J Clin Psychiatry (2007) 1.61

Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophr Res (2003) 1.60

The relationship between performance and fMRI signal during working memory in patients with schizophrenia, unaffected co-twins, and control subjects. Schizophr Res (2006) 1.57

Age at onset and cognitive functioning in schizophrenia. Br J Psychiatry (2004) 1.54

Geographic variation and sociodemographic characteristics of psychotic disorders in Finland. Schizophr Res (2008) 1.54

Self-inflicted burns: an eight year retrospective study in Finland. Burns (2004) 1.52

Seasonal changes, sleep length and circadian preference among twins with bipolar disorder. BMC Psychiatry (2003) 1.51

Statin usage and all-cause and disease-specific mortality in a nationwide study. Pharmacoepidemiol Drug Saf (2011) 1.50

Premorbid intellectual functioning in bipolar disorder and schizophrenia: results from a cohort study of male conscripts. Am J Psychiatry (2005) 1.48

DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population--results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol (2005) 1.48

Sex differences in cognition among persons with schizophrenia and healthy first-degree relatives. Psychiatry Res (2010) 1.46

Level of suicidal intent predicts overall mortality and suicide after attempted suicide: a 12-year follow-up study. BMC Psychiatry (2004) 1.39

Hippocampal volumes in schizophrenic twins. Arch Gen Psychiatry (2004) 1.37

Determinants and outcomes of serious attempted suicide: a nationwide study in Finland, 1996-2003. Am J Epidemiol (2008) 1.35

Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry (2002) 1.35

A twin study of genetic contributions to hippocampal morphology in schizophrenia. Neurobiol Dis (2002) 1.33

Genetic contributions to altered callosal morphology in schizophrenia. J Neurosci (2002) 1.33

Poststroke depression: an 18-month follow-up. Stroke (2003) 1.31

Major depressive disorder and white matter abnormalities: a diffusion tensor imaging study with tract-based spatial statistics. J Affect Disord (2010) 1.28

Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments. Hum Mol Genet (2007) 1.28

Families with the risk allele of DISC1 reveal a link between schizophrenia and another component of the same molecular pathway, NDE1. Hum Mol Genet (2006) 1.28

Burnout in the general population. Results from the Finnish Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol (2006) 1.27

At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia. Biol Psychiatry (2011) 1.26

No mental health without physical health. Lancet (2011) 1.22

Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med (2005) 1.21

Depression among caregivers of stroke survivors. Stroke (2005) 1.18

NPAS2 and PER2 are linked to risk factors of the metabolic syndrome. J Circadian Rhythms (2009) 1.15

Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. J Clin Psychiatry (2008) 1.13

Heritability and number of quantitative trait loci of neurocognitive functions in families with schizophrenia. Am J Med Genet (2002) 1.13

Seasonal changes in mood and behavior are linked to metabolic syndrome. PLoS One (2008) 1.11

Employment status, mental disorders and service use in the working age population. Scand J Work Environ Health (2007) 1.10

Work stress, mental health and antidepressant medication findings from the Health 2000 Study. J Affect Disord (2006) 1.10

ARNTL (BMAL1) and NPAS2 gene variants contribute to fertility and seasonality. PLoS One (2010) 1.09

A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. Hum Mol Genet (2010) 1.08

Depression and C-reactive protein: population-based Health 2000 Study. Psychosom Med (2009) 1.08

Hazardous drinking: prevalence and associations in the Finnish general population. Alcohol Clin Exp Res (2008) 1.08

Alcohol-induced psychotic disorder and delirium in the general population. Br J Psychiatry (2010) 1.07

Spatial working memory function in twins with schizophrenia and bipolar disorder. Biol Psychiatry (2005) 1.06

Childhood adversities as risk factors for adult mental disorders: results from the Health 2000 study. Soc Psychiatry Psychiatr Epidemiol (2005) 1.06

Assessment of depression after stroke: a comparison of different screening instruments. Stroke (2008) 1.06

The health-related quality-of-life impact of chronic conditions varied with age in general population. J Clin Epidemiol (2007) 1.06

Reduced left hemispheric white matter volume in twins with bipolar I disorder. Biol Psychiatry (2003) 1.05